Skip to main content

ELI LILLY & Co

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

LLY$1,432.29+1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Condensed Balance Sheets

June 30, 2025December 31, 2024
Assets · (Unaudited)
Current Assets
Cash and cash equivalents (Note 7)$3,375.9$3,268.4
Short-term investments (Note 7)170.1154.8
Accounts receivable, net of allowances of $16.1 (2025) and $14.9 (2024)14,170.411,005.7
Other receivables3,035.22,269.7
Inventories (Note 6)11,013.87,589.2
Prepaid expenses (Note 8)18,019.88,340.5
Other current assets68.8111.4
Total current assets49,854.032,739.7
Investments (Note 7)3,207.43,215.9
Goodwill5,770.55,770.3
Other intangibles, net5,908.36,166.3
Deferred tax assets9,427.48,000.6
Property and equipment, net of accumulated depreciation of $12,554.0 (2025) and $11,789.0 (2024)20,529.717,102.4
Other noncurrent assets6,225.35,719.7
Total assets$100,922.6$78,714.9
Liabilities and Equity
Current Liabilities
Short-term borrowings and current maturities of long-term debt$5,723.7$5,117.1
Accounts payable4,075.73,228.6
Employee compensation1,303.02,093.9
Sales rebates and discounts14,537.411,539.3
Dividends payable1,345.21,346.3
Short-term income taxes payable6,958.01,116.4
Other current liabilities5,076.93,935.0
Total current liabilities39,019.928,376.6
Noncurrent Liabilities
Long-term debt34,180.128,527.1
Accrued retirement benefits (Note 9)1,344.51,300.5
Long-term income taxes payable5,684.34,060.9
Other noncurrent liabilities2,344.72,178.2
Total noncurrent liabilities43,553.636,066.7
Commitments and Contingencies (Note 10)
Eli Lilly and Company Shareholders' Equity
Common stock592.0592.4
Additional paid-in capital7,089.37,439.3
Retained earnings17,376.213,545.0
Employee benefit trust(3,013.2)(3,013.2)
Accumulated other comprehensive loss (Note 11)(3,716.0)(4,321.9)
Cost of common stock in treasury(55.4)(49.5)
Total Eli Lilly and Company shareholders' equity18,272.914,192.1
Noncontrolling interests76.279.5
Total equity18,349.114,271.6
Total liabilities and equity$100,922.6$78,714.9
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.